1-(4-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-n-methylmethanamine, 98%, 1g

Methyl 3-(methoxysulfinyl)propanoate, 95.0%, 1g

2-ethyl-N-methoxy-N-methylbutanamide, 95.0%, 10g

N-(3-((6-((3-(TRIFLUOROMETHYL)PHENYL)AMINO)PYRIMIDIN-4-YL)AMINO)PHENYL)CYCLOPROPANECARBOXAMIDE, 95%, 100mg

4-Bromo-5-(difluoromethyl)-1H-pyrazole, 95.0%, 100mg

6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-2-amine dihydrochloride, 95.0%, 1g

4,4',4''-Tris(diphenylamino)triphenylamine>97.0%(HPLC)(N)1g

3-Bromo-2-cyano-5-methoxypyridine, 5g

4-CHLORO-5,5-DIMETHYL-5H,6H,7H-PYRROLO[2,3-D]PYRIMIDIN-6-ONE, 95.0%, 1g

(5-Chloro-3-(4-(methylsulfonyl)phenyl)-[2,3'-bipyridin]-6'-yl)methanol (Etoricoxib Impurity), 97%, 50mg

Plan Fluarex PLFi 20x/0.50 IOS infinity corrected objective. Working distance 1.5 mm

(2S,3S)-3-Hydroxy-2-(4-methoxyphenyl)-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one, 95.0%, 25g

6-Bromo-3-chloro-4-methylpyridazine, 97%, 250mg